Medmain inc.

All

All Media(31) News(71) Press Release(32)

2025.05.09 | News

Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play
2025.01.10 | News

Announcement of Participation in the Japan Night – 43rd Annual J.P. Morgan Healthcare Conference
2025.01.08 | News

Medmain Acquires ISO/IEC 27001 Certification for an Information Security Management System
2024.12.20 | News

Our CEO Osamu Iizuka had a presentation at Korea-Japan Startup Founder’s Day!
2024.12.03 | News

Notice of New Year Holidays
2024.11.13 | Media

Our CEO Osamu Iizuka will have a presentation at Korea-Japan Startup Founder’s Day!
2024.10.29 | Media

We participated in the 1st Annual Congress of the Asian Society of Digital Pathology (ASDP 2024 Seoul)!
2024.10.16 | News

We participated in the 8th Digital Pathology & AI Congress Asia 2024!
2024.09.12 | News

Notice of Acquisition of a First-Class Marketing License for Medical Devices
2024.09.04 | News

【Announcement of Participation in the 8th Digital Pathology & AI Congress Asia 2024】
2024.03.11 | News

We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups
2024.02.27 | News

Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo
2023.12.11 | News

We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Vietnam!
2023.12.07 | News

Notice of New Year Holidays
2023.11.07 | News

【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】
2023.10.31 | News

【Announcement of Participation in the “Viet Nam – Japan Medical ICT and Aging Workshop” hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】
2023.09.13 | Media

Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
2023.08.03 | News

The Ambassador of the United Arab Emirates visited our office!
2023.05.23 | Media

Successful Development of Artificial Intelligence to Enable Classification of Cutaneous Melanoma in a Whole Slide Image of Dermatopathology ~ Published in Cancers
2023.05.19 | Media

Successful Development of Artificial Intelligence to Enable Detection of Prostate Cancer for Surveillance and Radical Treatment -Published in BMC Cancer-
2023.04.03 | Media

Successful Development of Artificial Intelligence to Infer Histological Views From Whole Slide Images and Generate Them Into Text – Published in Proceedings of Machine Learning Research –

News

Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play

Announcement of Participation in the Japan Night – 43rd Annual J.P. Morgan Healthcare Conference

Medmain Acquires ISO/IEC 27001 Certification for an Information Security Management System

Our CEO Osamu Iizuka had a presentation at Korea-Japan Startup Founder’s Day!

Notice of New Year Holidays

Our CEO Osamu Iizuka will have a presentation at Korea-Japan Startup Founder’s Day!

We participated in the 1st Annual Congress of the Asian Society of Digital Pathology (ASDP 2024 Seoul)!

We participated in the 8th Digital Pathology & AI Congress Asia 2024!

Notice of Acquisition of a First-Class Marketing License for Medical Devices

【Announcement of Participation in the 8th Digital Pathology & AI Congress Asia 2024】

We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups

Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo

We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Vietnam!

Notice of New Year Holidays

【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】

【Announcement of Participation in the “Viet Nam – Japan Medical ICT and Aging Workshop” hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】

Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech

The Ambassador of the United Arab Emirates visited our office!

Successful Development of Artificial Intelligence to Enable Classification of Cutaneous Melanoma in a Whole Slide Image of Dermatopathology ~ Published in Cancers

Successful Development of Artificial Intelligence to Enable Detection of Prostate Cancer for Surveillance and Radical Treatment -Published in BMC Cancer-

Successful Development of Artificial Intelligence to Infer Histological Views From Whole Slide Images and Generate Them Into Text – Published in Proceedings of Machine Learning Research –